Kathleen Day

1PUBLICATIONS
0CO-AUTHORS
Glycoconjugates
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (1)

|Feb 07, 2021
Effect of galcanezumab on severity and symptoms of migraine in phase 3 trials in patients with episodic or chronic migraine.

Michael Ament, Kathleen Day, Virginia L Stauffer

Pageof 1

Frequent Collaborators